$DAVA

Top Wall Street Forecasters Revamp Endava Expectations Ahead Of Q1 Earnings - Endava (NYSE:DAVA)

Endava plc ( NYSE:DAVA ) will release earnings results for the first quarter before the opening bell on Tuesday, Nov. 11. Analysts expect the company to report quarterly earnings at 18 cents per share. That's down from 25 cents per share in the year-ago period.

Original reporting
Benzinga · Avi Kapoor
Published Nov 11, 2025, 9:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2025, 10:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top Wall Street Forecasters Revamp Endava Expectations Ahead Of Q1 Earnings - Endava (NYSE:DAVA) — source image
Decision brief

The 30-second read

$DAVABullishMed
01

Why it matters

Earnings shortfall may lead to short-term stock price decline, but bullish sentiment suggests some investors remain optimistic about the company's prospects.

02

Market read

The earnings report is significant for traders and investors focusing on technology stocks and the broader financial markets.

03

What to watch

Potential for positive guidance or other company-specific news to offset earnings shortfall.

Timing: Immediate, as earnings release is scheduled for today.

Background

Endava is scheduled to release Q1 earnings, with analysts expecting a decrease in EPS from 25 cents to 18 cents, indicating a cautious outlook.

Company-level read

Ticker impact

$DAVABullishMedium confidence
Context

High relevance due to earnings report and analyst expectations.

Expected impact

Moderate short-term decline followed by stabilization or slight recovery.

Evidence & confidence

Earnings decline may pressure stock price initially, but bullish sentiment indicates underlying confidence, possibly due to long-term growth prospects or market positioning.

Market effects

Potential negative impact on the Technology and Financial sectors if earnings disappoint.

Limited, as the news pertains to a US-listed company with moderate global relevance.

Low to moderate; depends on the company's international exposure and market sentiment.

Counterpoint

The earnings decline may be a temporary setback, and bullish sentiment could lead to a quick recovery post-earnings.

Key entities

  • Endava plc

    A technology services company listed on NYSE.

Related articles

$DAVAMed

Here is Why Endava (DAVA) is One of the Underperforming Tech Stocks to Buy According to Analysts

Endava (NYSE:DAVA) reported FQ3 2026 revenue of £178.5 million, down 8.4% year over year, citing uneven demand and longer deal cycles. The company recorded a £364.6 million goodwill impairment and related tax charges, resulting in a diluted loss per share of £7.55. For FQ4, it expects revenue of £181.0–£185.0 million and adjusted diluted EPS of £0.09–£0.13.

$CWMed

Curtiss-Wright Slides As Investors Question CEO Handoff

Curtiss-Wright (CW) shares fell as investors reacted to a planned leadership transition, with the current COO set to become CEO in 2027. Concerns about strategic continuity and execution risk were raised, despite the company's strong financial position and growth prospects. Quarterly results may be volatile due to cash conversion and supply chain pressures.

$HCAMed

BMO starts HCA Healthcare stock at Outperform on growth outlook

BMO Capital initiated coverage on HCA Healthcare (NYSE:HCA) with an Outperform rating and $495 price target, citing growth drivers like demographic trends and digital transformation. HCA trades at $438.16 with $95.43B market cap, and reported Q2 2026 earnings beating estimates but lowered full-year guidance. Analysts have mixed reactions with varied price targets and ratings.